A Phase II Study of Long-Acting Octreotide in Patients With Advanced Hepatocellular Carcinoma and CLIP Score of 3 or Higher

BACKGROUND: Studies of octreotide in hepatocellular carcinoma have yielded conflicting results. Since past studies have excluded patients with highly advanced disease and given the fact that octreotide offers several potential physiologic benefits in patients with advanced cirrhosis, such as improvi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Shah, Usman, O’Neil, Bert, Allen, Jill, Goldberg, Richard M., Bernard, Steven, Moore, Dominic, Venook, Alan P., Morse, Michael M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: International Society of Gastrointestinal Oncology 2009
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2684718/
https://ncbi.nlm.nih.gov/pubmed/19461906
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak